![]() |
|
|
Molecular Pharmacology, Vol 6, 251-254, Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology, University of Rochester School of Medicine, Rochester, New York 14620, and
Arthur D. Little Corporation, Cambridge, Massachusetts 02140
The responsiveness to 5-fluoro-2'-deoxyuridine of different transplantable mouse leukemias in vivo was inversely correlated with tumor cell levels of thymidine kinase (EC 2.7.1.21). This enzyme transforms the drug to the pharmacologically active nucleotide 5-fluoro-2'-deoxyuridylic acid. However, it also provides an alternative pathway for circumventing time drug-induced blockade of thymidylate biosynthesis.
Note:
ACKNOWLEDGMENTS
Technical assistance was provided by Regina
Bruns (at the University of Rochester) and Albert
Ross (at Arthur D. Little Corporation).